Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800018516Phase 4Completed
Phase 4, open-label, single-arm trial of esomeprazole, sponsored by Lishui City Central Hospital. Primary endpoints: Plasma albumin, Blood concentration of esomeprazole and 1 more. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800018516.